Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Fennec Pharmaceuticals
(FENC)
NASDAQ
:FENC
FENC
Fennec Pharmaceuticals
Overview
Analyst Forecasts
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Fennec Pharmaceuticals (FENC) Stock News & Sentiment
AI Analyst Report
Follow
255
Followers
Premium
Ratings
Buy Rating on PEDMARK Undervalues Global Expansion and Pipeline Upside, Supporting $13 Target Price
1d ago
FENC
Premium
Company Announcements
Fennec Backs New PEDMARK Study Expanding Cisplatin Ototoxicity Research to Adult Cancers
2d ago
FENC
Premium
Ratings
Fennec Pharmaceuticals: Buy Rating Reaffirmed on Accelerating PEDMARK Adoption and Multi-Region Growth Catalysts Through 2027
10d ago
FENC
Premium
Company Announcements
Fennec Pharmaceuticals Signals Costly Push Toward Growth
13d ago
FENC
Premium
Company Announcements
Fennec Posts Record PEDMARK Sales in 2025 as Clinical and Commercial Momentum Builds
13d ago
FENC
Premium
Company Announcements
Fennec Pharmaceuticals Posts Record PEDMARK Sales and Broadens Clinical Footprint in 2025
16d ago
FENC
Premium
Pre-Earnings
Is FENC a Buy, Before Earnings?
18d ago
FENC
More FENC News >
FENC News on the Web
All News
Bearish News
Bullish News
2026-04-08
Fennec Pharmaceuticals Launches Investigator-Sponsored Of PEDMARK In AYA And Adult Cancer Patients
rttnews
Neutral
2026-04-08
Buy Rating on PEDMARK Undervalues Global Expansion and Pipeline Upside, Supporting $13 Target Price
TipRanks News
Neutral
2026-04-07
Analysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI) and Fennec Pharmaceuticals (FENC)
TipRanks News
Neutral
2026-03-30
Fennec Pharmaceuticals: Buy Rating Reaffirmed on Accelerating PEDMARK Adoption and Multi-Region Growth Catalysts Through 2027
TipRanks News
Bullish
2026-03-28
Fennec Pharmaceuticals Signals Costly Push Toward Growth
TipRanks News
Bullish
2026-03-25
Fennec Pharmaceuticals (FENC) Gets a Buy from Wedbush
TipRanks News
Bullish
2026-03-25
Piper Sandler Sticks to Their Buy Rating for Fennec Pharmaceuticals (FENC)
TipRanks News
Bullish
2026-03-24
Fennec Pharmaceuticals Inc (FENC) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ...
GuruFocus News
Bullish
119
Results | Showing
1
out of
15
News Score - Last 7 Days
Neutral
FENC
Sector Average
Media Buzz
This Week
3 articles
Weekly Average
4.25 articles
News Sentiment
This Week
50%
Sector Average
68%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is FENC’s Media Buzz Sentiment?
3 articles about FENC were published this week. In an average week, 4.25 articles are published.
What is FENC’s weekly average amount of articles?
In an average week, 4.25 articles about FENC are published.
What is FENC’s News Sentiment?
50% of articles about FENC were positive this week, compared to its sector average of 68%.
Healthcare Stocks that are Trending in the News
NBIX
Neurocrine
AORT
Artivion
STAA
Staar Surgical
HUM
Humana
ORGO
Organogenesis Holdings
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.